TMO
Thermo Fisher Scientific Inc. (TMO)
Last Price$523.6(1.0%)
Market Cap$201.0B
Last Earnings date
Sep'24
Q3 2024
$4.79
19.4% miss
Next quarter EPS Estimate
$5.94
4.8%YoY

TMO Earnings and Expectations

Revenue

Crunching data... Almost there!

TMO EPS (Earnings Per Share)

Crunching data... Almost there!

TMO Historical Revenue & EPS and Expectations

1Y
3Y
5Y
10Y
Revenue
EPS
$0.0$2,000.0M$4,000.0M$6,000.0M$8,000.0M$10.0B$12.0BApr'20Jul'20Oct'20Jan'21Apr'21Jul'21Oct'21Jan'22Apr'22Jul'22Oct'22Jan'23Apr'23Jul'23Oct'23Jan'24Apr'24Jul'24Oct'24$6,230.0M$8,521.0M$9,906.0M$9,330.0M$11.8B$10.7B$10.7B$10.6B$10.3B$10.6B
Value Sense
Actual Revenue
Forecast Revenue

TMO Earnings History

Mar'15Jun'15Sep'15Dec'15Apr'16Jul'16Oct'16Dec'16Apr'17Jul'17Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Apr'21Jul'21Oct'21Dec'21Apr'22Jul'22Oct'22Dec'22Apr'23Jul'23Sep'23Dec'23Mar'24Jun'24Sep'24Dec'24
Revenue actual$3,918.8M$4,270.9M$4,123.2M$4,652.5M$4,294.8M$4,535.2M$4,490.9M$4,953.2M$4,765.0M$4,990.0M$5,116.2M$6,047.0M$5,853.0M$6,078.0M$5,920.0M$6,507.0M$6,125.0M$6,316.0M$6,272.0M$6,829.0M$6,230.0M$6,917.0M$8,521.0M$10.6B$9,906.0M$9,273.0M$9,330.0M$10.7B$11.8B$11.0B$10.7B$11.5B$10.7B$10.7B$10.6B$10.9B$10.3B$10.5B$10.6B$11.4B
Revenue estimate$3,571.8M$3,870.7M$3,870.7M$3,870.7M$3,870.7M$3,870.7M$3,870.7M$4,891.5M$4,891.5M$4,891.5M$4,983.3M$4,983.3M$5,618.9M$5,618.9M$5,618.9M$5,618.9M$6,022.9M$6,303.4M$6,303.4M$6,779.6M$6,779.6M$6,165.3M$6,098.1M$9,579.2M$9,717.5M$8,728.6M$8,377.0M$8,713.2M$10.7B$9,967.0M$9,943.7M$10.4B$10.7B$11.0B$10.6B$10.7B$10.2B$10.5B$10.6B$11.3B
Revenue surprise9.7%10.3%6.5%20.2%11.0%17.2%16.0%1.3%2.6%2.0%2.7%21.3%4.2%8.2%5.4%15.8%1.7%0.2%0.5%0.7%8.1%12.2%39.7%10.1%1.9%6.2%11.4%22.8%10.5%10.1%7.4%9.8%0.5%2.7%0.2%1.4%1.9%0.3%0.3%0.9%
EPS actual$0.97$1.28$1.19$1.51$1.02$1.31$1.20$1.60$1.41$1.57$1.35$1.32$1.44$1.87$1.76$2.23$2.04$2.80$1.89$2.51$1.99$2.92$4.88$6.30$5.93$4.65$4.83$4.20$5.65$4.24$3.81$4.03$3.34$3.53$4.44$4.21$3.48$4.05$4.27$4.79
EPS estimate$1.27$1.59$1.59$1.59$1.59$1.59$1.59$2.35$2.35$2.35$2.19$2.19$2.30$2.30$2.30$2.30$2.73$3.00$3.00$3.54$3.54$2.80$2.89$6.56$6.66$5.47$4.68$4.93$6.22$4.99$4.83$5.20$5.03$5.42$5.61$5.64$4.71$5.12$5.24$5.95
EPS surprise23.6%19.5%25.2%5.0%35.8%17.6%24.5%31.9%40.0%33.2%38.4%39.7%37.4%18.7%23.5%3.0%25.3%6.6%36.9%29.1%43.8%4.4%68.9%4.0%10.9%15.0%3.2%14.8%9.1%15.0%21.2%22.4%33.6%34.9%20.9%25.4%26.1%20.9%18.5%19.4%

Overview of financial statements

Income statement
Balance sheet
Cash Flow statement
$11.4B 4.7% YoY
$4,903.0M 9.1% YoY
43.0% margin
Cost of revenue
$6,492.0M 1.6% YoY
Operating income
$2,016.0M 8.7% YoY
17.7% margin
Other: $618.0M
Net interest: $543.0M
Operating expenses
$2,887.0M 9.3% YoY
Pre-tax income
$1,941.0M 11.6% YoY
17.0% margin
Net income
$1,830.0M 12.3% YoY
16.1% margin
Income tax
$150.0M
(7.7%) tax rate
R&D
$374.0M 14.4% YoY
3.3% of revenue
SG&A
$1,846.0M 10.4% YoY
16.2% of revenue

Competing with TMO Earnings

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name
Market Cap
Revenue
EPS
Last quarter Revenue growth
Last quarter EPS growth
Last quarter Revenue surpriseLast quarter EPS surprise
Next quarter Revenue growth
Next quarter EPS growth
Last 10 Earnings (how many miss vs beat)
1Y Fwd Revenue growth
1Y Fwd EPS growth
$201.0B
$42.9B
$16.59
4.7%
13.8%
Beat by 0.9%
Miss by 19.4%
(6.3%)
11.6%
Beats: 8
Misses: 2
(0.2%)
39.8%
$151.3B
$23.9B
$5.33
142.8%
2.7%
Beat by 2.2%
Miss by 30.2%
(9.0%)
32.5%
Beats: 9
Misses: 1
4.1%
55.3%
$36.5B
$6,533.0M
$4.36
1.4%
(5.9%)
undefinedN/A
undefinedN/A
(1.7%)
16.8%
Beats: 9
Misses: 1
4.9%
25.6%
$36.1B
$3,897.5M
$10.76
5.8%
12.4%
Beat by 2.1%
Beat by 9.6%
7.3%
14.1%
Beats: 9
Misses: 1
5.9%
2.8%
$33.7B
$15.4B
$7.58
1.3%
(5.4%)
Beat by 0.8%
Miss by 21.5%
(2.5%)
8.1%
Beats: 10
Misses: 0
4.2%
57.9%
$27.1B
$3,872.4M
$40.64
11.8%
40.2%
Beat by 3.6%
Beat by 2.4%
(13.5%)
(33.1%)
Beats: 8
Misses: 2
1.9%
3.9%
$22.2B
$2,958.4M
$10.76
6.5%
6.6%
Beat by 1.9%
Miss by 3.2%
(22.6%)
(38.0%)
Beats:
Misses:
(0.5%)
8.5%
$21.2B
$13.0B
$8.89
9.8%
N/A
Beat by 0.6%
Miss by 49.3%
2.5%
124.9%
Beats: 7
Misses: 3
N/A
N/A
$19.6B
$9,872.0M
$7.80
14.6%
17.0%
Beat by 1.6%
Miss by 8.5%
0.1%
10.4%
Beats: 9
Misses: 1
6.2%
17.3%
$18.5B
$1,532.0M
($1.77)
63.9%
(72.6%)
Beat by 28.2%
Miss by 62.2%
(3.2%)
72.5%
Beats: 7
Misses: 3
51.7%
(58.5%)

FAQ

1. When was Thermo Fisher Scientific Inc.'s last earnings date?

Thermo Fisher Scientific Inc.'s last earnings date was Sep'24 (Q3 2024).

2. What is Thermo Fisher Scientific Inc.'s EPS, and was there a surprise?

4. What is Thermo Fisher Scientific Inc.'s next quarter EPS estimate?

Thermo Fisher Scientific Inc.'s next quarter EPS estimate is $5.94, with an expected 4.8% YoY growth.